Loading...
Shensu IV prevents glomerular podocyte injury in nephrotic rats via promoting lncRNA H19/DIRAS3-mediated autophagy
Shensu IV is a Chinese prescription well-known for its function in treating chronic kidney diseases. However, the potential mechanisms underlying how Shensu IV exerts its effects remain unclear. In the present study, we investigated the effects of Shensu IV on glomerular podocyte injury in nephrotic...
Saved in:
| Published in: | Biosci Rep |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Portland Press Ltd.
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8112846/ https://ncbi.nlm.nih.gov/pubmed/33881140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20203362 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|